Product Name:
CAS No.: 380610-27-5
Molecular Weight: 148 kDa
Type: Whole antibody
Target: HER2
Antibody Form: Purified immunoglobulin
Physical Form: Solution
Storage:
Description
Pertuzumab(trade name Perjeta) is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). Pertuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture that may contain the antibiotic, gentamicin. Gentamicin is not detectable in the final product. Pertuzumab has an approximate molecular weight of 148 kDa.
Biological Activity
Pertuzumab (anti-HER2), a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors, impairs the ability of HER2 to bind to other members of the HER family
For research use only. Not for use in humans